VSee Health, Inc.

VSEE Healthcare Health Information Services

VSee Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.6 million, up 40.3% from fiscal 2024.

Revenue
−53.9%
EPS
+109.9%
Free cash flow
−257.6%
Total debt
+31.6%

Quarter to June 2026, against a year earlier

1.15 0.00 0.00%
Market cap
$2.8M
P/E
0.0×
Fwd P/E
−2.2×
Dividend yield
—
F-score
4/9
Altman Z
−6.06
Beneish M
−4.22
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

— — 4 4
ROE
2,466.75% (541.52%) (945.70%) (1,065.78%)
ROA
(46.05%) (69.39%) (69.53%) (56.62%)
ROIC
0.00% (602.00%) (116.45%) (93.65%)
Return on Tangible Assets
52.22% 193.99% 199.66% 209.77%
Average Days of Receivables
65.24 55.96 67.44 64.48
Free Cash Flow per Share
(21.93) (13.86) (9.21) (9.40)
Free Cash Flow
(4.54) (3.49) (5.52) (6.31)
Capital Expenditures
(0.04) (0.05) (0.06) —
Other line items
Cash ROIC
100.53% (31.46%) (65.31%) (71.43%)
Accounts Receivable Turnover
5.56 7.39 6.39 6.56
Accounts Payable Turnover
0.52 0.78 0.86 1.08
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
828.44 468.95 401.06 269.01
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
0.00 0.22 0.00 (0.01)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
106.19% 115.87% 120.50% 143.74%
Share Based Compensation of Revenue
8.02% 7.69% 8.12% 7.95%
Interest Coverage
(5.83) (3.41) (4.89) (5.78)
Operating CF/Net income
0.45 0.23 0.41 0.64
Depreciation/Fixed assets
6.48 9.00 9.94 23.09
Capex/Depreciation
(0.02) (0.02) (0.02) 0.00
Revenue per Share
69.73 58.06 24.14 18.83
Operating CF per Share
(21.72) (13.68) (9.11) (9.40)
Capex per Share
(0.21) (0.18) (0.10) 0.00
Capex to Sales
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates · fundamentals updated 2 Nov 2026